Teva prevails in Treanda validity dispute

13-06-2016

Teva prevails in Treanda validity dispute

Photo: Courtesy of Teva

Teva Pharmaceutical announced last Friday, June 10, that the US District Court for the District of Delaware ruled that four patents for the Treanda (bendamustine hydrochloride) injection are valid.


Treanda, Teva, US District Court for the District of Delaware, Hetero, InnoPharma, Hospira, Sagent, Accord, patent

LSIPR